Nxera Pharma
corporate_fare Company Profile
Nxera Pharma (OTC:SOLTF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for SOLTF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10.
Recent high-impact activity:
- AbbVie Pays $100M Upfront in $1.5B Bowel Disease Licensing Deal
Short Interest & Short Volume
FINRA reported short interest of 1,900,311 shares in SOLTF as of the October 30, 2026 settlement, a 11.6% increase from the prior period. On November 20, 2026, 67.6% of SOLTF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.